BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12023846)

  • 1. Mechanism of thrombin-induced angiogenesis.
    Maragoudakis ME; Tsopanoglou NE; Andriopoulou P
    Biochem Soc Trans; 2002 Apr; 30(2):173-7. PubMed ID: 12023846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of thrombin in angiogenesis and tumor progression.
    Tsopanoglou NE; Maragoudakis ME
    Semin Thromb Hemost; 2004 Feb; 30(1):63-9. PubMed ID: 15034798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.
    Abdollahi A; Lipson KE; Han X; Krempien R; Trinh T; Weber KJ; Hahnfeldt P; Hlatky L; Debus J; Howlett AR; Huber PE
    Cancer Res; 2003 Jul; 63(13):3755-63. PubMed ID: 12839971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis.
    Scarpino S; D'Alena FC; Di Napoli A; Ballarini F; Prat M; Ruco LP
    J Pathol; 2003 Feb; 199(2):243-50. PubMed ID: 12533838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
    Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
    Kim MH
    J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
    Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of human NK cell lines by vascular endothelial growth factor and receptor VEGFR-1 (FLT-1).
    Chen WS; Kitson RP; Goldfarb RH
    In Vivo; 2002; 16(6):439-45. PubMed ID: 12494887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.
    Reynolds LE; Wyder L; Lively JC; Taverna D; Robinson SD; Huang X; Sheppard D; Hynes RO; Hodivala-Dilke KM
    Nat Med; 2002 Jan; 8(1):27-34. PubMed ID: 11786903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
    Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation proteases and human cancer.
    Sampson MT; Kakkar AK
    Biochem Soc Trans; 2002 Apr; 30(2):201-7. PubMed ID: 12023851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells.
    Jiang C; Agarwal R; Lü J
    Biochem Biophys Res Commun; 2000 Sep; 276(1):371-8. PubMed ID: 11006131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
    Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.